Concepts (281)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cannabis | 16 | 2025 | 90 | 5.690 |
Why?
|
| Decision Making | 23 | 2023 | 242 | 5.250 |
Why?
|
| Marijuana Abuse | 15 | 2021 | 93 | 4.460 |
Why?
|
| Neuropsychological Tests | 39 | 2025 | 281 | 3.980 |
Why?
|
| Conduct Disorder | 6 | 2021 | 54 | 3.580 |
Why?
|
| Marijuana Smoking | 9 | 2018 | 90 | 2.890 |
Why?
|
| Adolescent Behavior | 6 | 2021 | 270 | 2.580 |
Why?
|
| Substance-Related Disorders | 27 | 2021 | 825 | 2.530 |
Why?
|
| Brain | 24 | 2025 | 1452 | 2.500 |
Why?
|
| Risk-Taking | 10 | 2019 | 456 | 2.350 |
Why?
|
| Cognition | 18 | 2025 | 458 | 1.970 |
Why?
|
| Adolescent | 39 | 2025 | 5950 | 1.950 |
Why?
|
| Gambling | 8 | 2023 | 21 | 1.940 |
Why?
|
| Sex Characteristics | 8 | 2021 | 253 | 1.520 |
Why?
|
| Cognition Disorders | 13 | 2013 | 243 | 1.510 |
Why?
|
| Humans | 106 | 2025 | 42163 | 1.500 |
Why?
|
| Sexual Behavior | 5 | 2018 | 634 | 1.490 |
Why?
|
| HIV Infections | 21 | 2025 | 2535 | 1.460 |
Why?
|
| Longitudinal Studies | 14 | 2025 | 1020 | 1.440 |
Why?
|
| Schools | 2 | 2025 | 283 | 1.400 |
Why?
|
| Executive Function | 4 | 2025 | 55 | 1.310 |
Why?
|
| Male | 71 | 2025 | 22779 | 1.310 |
Why?
|
| Female | 66 | 2025 | 24018 | 1.230 |
Why?
|
| Reward | 4 | 2020 | 106 | 1.220 |
Why?
|
| Psychomotor Performance | 8 | 2015 | 156 | 1.220 |
Why?
|
| Motivation | 4 | 2021 | 492 | 1.080 |
Why?
|
| Environmental Monitoring | 3 | 2025 | 226 | 0.980 |
Why?
|
| Child | 18 | 2025 | 3381 | 0.960 |
Why?
|
| Feces | 3 | 2025 | 126 | 0.950 |
Why?
|
| Punishment | 1 | 2025 | 7 | 0.920 |
Why?
|
| Anxiety Disorders | 2 | 2018 | 319 | 0.920 |
Why?
|
| Learning | 7 | 2018 | 155 | 0.890 |
Why?
|
| Attention Deficit and Disruptive Behavior Disorders | 2 | 2021 | 55 | 0.830 |
Why?
|
| Impulsive Behavior | 6 | 2015 | 54 | 0.820 |
Why?
|
| Attention | 6 | 2019 | 165 | 0.810 |
Why?
|
| Adolescent Development | 5 | 2025 | 39 | 0.800 |
Why?
|
| Emotions | 3 | 2021 | 251 | 0.780 |
Why?
|
| Memory Disorders | 6 | 2023 | 77 | 0.770 |
Why?
|
| HIV Seropositivity | 11 | 2016 | 196 | 0.770 |
Why?
|
| Adult | 48 | 2025 | 13458 | 0.760 |
Why?
|
| Attention Deficit Disorder with Hyperactivity | 3 | 2025 | 297 | 0.730 |
Why?
|
| Residence Characteristics | 1 | 2025 | 359 | 0.720 |
Why?
|
| Mental Recall | 5 | 2016 | 81 | 0.710 |
Why?
|
| Social Environment | 2 | 2021 | 218 | 0.670 |
Why?
|
| Coronavirus | 1 | 2020 | 9 | 0.670 |
Why?
|
| Psychometrics | 7 | 2021 | 350 | 0.670 |
Why?
|
| Depressive Disorder | 2 | 2018 | 185 | 0.650 |
Why?
|
| Cross-Sectional Studies | 9 | 2023 | 3077 | 0.620 |
Why?
|
| Amphetamine-Related Disorders | 4 | 2013 | 69 | 0.620 |
Why?
|
| Cannabinoids | 3 | 2019 | 67 | 0.610 |
Why?
|
| Personality Assessment | 1 | 2019 | 44 | 0.610 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 81 | 0.590 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 86 | 0.590 |
Why?
|
| Multilingualism | 1 | 2019 | 50 | 0.580 |
Why?
|
| Mood Disorders | 1 | 2018 | 54 | 0.550 |
Why?
|
| Young Adult | 15 | 2019 | 4936 | 0.550 |
Why?
|
| Body Mass Index | 3 | 2023 | 916 | 0.540 |
Why?
|
| Methamphetamine | 4 | 2007 | 167 | 0.520 |
Why?
|
| Auditory Perception | 2 | 2006 | 66 | 0.480 |
Why?
|
| Prospective Studies | 7 | 2021 | 1574 | 0.480 |
Why?
|
| Anti-HIV Agents | 3 | 2017 | 475 | 0.470 |
Why?
|
| Middle Aged | 31 | 2025 | 11819 | 0.460 |
Why?
|
| Mental Processes | 2 | 2012 | 16 | 0.460 |
Why?
|
| Alcoholism | 4 | 2025 | 292 | 0.440 |
Why?
|
| Anxiety | 3 | 2017 | 847 | 0.410 |
Why?
|
| Magnetic Resonance Imaging | 6 | 2025 | 577 | 0.410 |
Why?
|
| Sewage | 2 | 2025 | 27 | 0.400 |
Why?
|
| Choice Behavior | 2 | 2013 | 91 | 0.390 |
Why?
|
| Heroin Dependence | 4 | 2015 | 23 | 0.380 |
Why?
|
| Mental Disorders | 3 | 2021 | 377 | 0.370 |
Why?
|
| Amygdala | 3 | 2021 | 125 | 0.360 |
Why?
|
| Serial Learning | 1 | 2011 | 5 | 0.360 |
Why?
|
| United States | 7 | 2025 | 5072 | 0.350 |
Why?
|
| Memory | 3 | 2013 | 175 | 0.340 |
Why?
|
| Individuality | 2 | 2022 | 53 | 0.330 |
Why?
|
| Disasters | 2 | 2022 | 74 | 0.330 |
Why?
|
| Analysis of Variance | 7 | 2017 | 574 | 0.330 |
Why?
|
| Cyclonic Storms | 2 | 2021 | 75 | 0.320 |
Why?
|
| Reproducibility of Results | 6 | 2019 | 1058 | 0.280 |
Why?
|
| Demography | 3 | 2006 | 195 | 0.270 |
Why?
|
| Gyrus Cinguli | 3 | 2021 | 30 | 0.260 |
Why?
|
| Case-Control Studies | 4 | 2017 | 1266 | 0.250 |
Why?
|
| Sex Factors | 3 | 2019 | 1008 | 0.240 |
Why?
|
| AIDS Dementia Complex | 2 | 2004 | 116 | 0.230 |
Why?
|
| Drug Resistance, Microbial | 1 | 2025 | 26 | 0.230 |
Why?
|
| Follow-Up Studies | 3 | 2023 | 1051 | 0.230 |
Why?
|
| Virginia | 2 | 2025 | 12 | 0.230 |
Why?
|
| Risk Factors | 5 | 2021 | 3942 | 0.230 |
Why?
|
| Rain | 1 | 2024 | 10 | 0.230 |
Why?
|
| Exploratory Behavior | 1 | 2005 | 78 | 0.220 |
Why?
|
| Virus Inactivation | 1 | 2024 | 1 | 0.220 |
Why?
|
| Neurotoxicity Syndromes | 1 | 2004 | 37 | 0.220 |
Why?
|
| Drug Users | 3 | 2015 | 51 | 0.220 |
Why?
|
| Disinfection | 1 | 2024 | 10 | 0.220 |
Why?
|
| Water Microbiology | 1 | 2024 | 82 | 0.210 |
Why?
|
| Ozone | 1 | 2024 | 26 | 0.210 |
Why?
|
| Depression | 3 | 2023 | 837 | 0.210 |
Why?
|
| Social Behavior | 1 | 2025 | 160 | 0.210 |
Why?
|
| Water Purification | 1 | 2024 | 33 | 0.210 |
Why?
|
| Comorbidity | 4 | 2018 | 725 | 0.210 |
Why?
|
| Hepatitis C | 3 | 2015 | 138 | 0.210 |
Why?
|
| Mental Health | 2 | 2018 | 363 | 0.200 |
Why?
|
| Cubozoa | 1 | 2023 | 16 | 0.200 |
Why?
|
| Computers | 1 | 2003 | 35 | 0.200 |
Why?
|
| Prefrontal Cortex | 2 | 2021 | 160 | 0.190 |
Why?
|
| Mass Media | 1 | 2021 | 38 | 0.180 |
Why?
|
| Stress Disorders, Post-Traumatic | 3 | 2021 | 547 | 0.180 |
Why?
|
| Pancreas, Exocrine | 1 | 2021 | 4 | 0.180 |
Why?
|
| Empathy | 1 | 2021 | 31 | 0.180 |
Why?
|
| Prenatal Exposure Delayed Effects | 1 | 2023 | 188 | 0.170 |
Why?
|
| Rotavirus | 1 | 2021 | 14 | 0.170 |
Why?
|
| Enterovirus | 1 | 2021 | 11 | 0.170 |
Why?
|
| Patient Acceptance of Health Care | 1 | 2025 | 471 | 0.170 |
Why?
|
| Disease Management | 1 | 2021 | 68 | 0.170 |
Why?
|
| Intelligence | 2 | 2019 | 14 | 0.170 |
Why?
|
| Personality | 3 | 2021 | 55 | 0.170 |
Why?
|
| Carcinoma, Pancreatic Ductal | 1 | 2021 | 60 | 0.160 |
Why?
|
| Drug Interactions | 2 | 2015 | 151 | 0.160 |
Why?
|
| Nucleus Accumbens | 1 | 2020 | 99 | 0.160 |
Why?
|
| Diagnostic Tests, Routine | 1 | 2019 | 51 | 0.150 |
Why?
|
| Medication Adherence | 1 | 2021 | 177 | 0.150 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2021 | 649 | 0.150 |
Why?
|
| Vocabulary | 1 | 2019 | 19 | 0.150 |
Why?
|
| Antisocial Personality Disorder | 2 | 2010 | 20 | 0.150 |
Why?
|
| Reaction Time | 4 | 2010 | 151 | 0.150 |
Why?
|
| Brain Mapping | 1 | 2019 | 132 | 0.150 |
Why?
|
| Cohort Studies | 3 | 2021 | 1729 | 0.150 |
Why?
|
| Factor Analysis, Statistical | 1 | 2019 | 157 | 0.150 |
Why?
|
| Pancreatic Neoplasms | 1 | 2021 | 206 | 0.140 |
Why?
|
| Behavior, Addictive | 1 | 2018 | 37 | 0.140 |
Why?
|
| Aggression | 1 | 2019 | 101 | 0.140 |
Why?
|
| Models, Statistical | 1 | 2019 | 190 | 0.140 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2019 | 170 | 0.140 |
Why?
|
| Verbal Learning | 3 | 2013 | 18 | 0.140 |
Why?
|
| Self Administration | 1 | 2017 | 67 | 0.130 |
Why?
|
| Social Class | 1 | 2019 | 286 | 0.130 |
Why?
|
| Regression Analysis | 3 | 2013 | 487 | 0.130 |
Why?
|
| Alcohol Drinking | 1 | 2021 | 585 | 0.130 |
Why?
|
| Psychoses, Substance-Induced | 1 | 2016 | 2 | 0.120 |
Why?
|
| Behavior | 1 | 2016 | 34 | 0.120 |
Why?
|
| Blood Pressure | 1 | 2019 | 662 | 0.120 |
Why?
|
| Parents | 1 | 2019 | 359 | 0.120 |
Why?
|
| Cocaine-Related Disorders | 3 | 2016 | 99 | 0.110 |
Why?
|
| Age of Onset | 1 | 2015 | 115 | 0.110 |
Why?
|
| Intelligence Tests | 2 | 2011 | 8 | 0.110 |
Why?
|
| Reference Values | 2 | 2012 | 207 | 0.110 |
Why?
|
| Buttocks | 1 | 2013 | 3 | 0.100 |
Why?
|
| Silicone Gels | 1 | 2013 | 2 | 0.100 |
Why?
|
| Visual Perception | 2 | 2016 | 75 | 0.100 |
Why?
|
| Statistics as Topic | 2 | 2013 | 123 | 0.100 |
Why?
|
| Time Factors | 3 | 2023 | 1848 | 0.100 |
Why?
|
| Prostheses and Implants | 1 | 2013 | 18 | 0.100 |
Why?
|
| Acquired Immunodeficiency Syndrome | 2 | 2013 | 225 | 0.100 |
Why?
|
| Models, Psychological | 1 | 2013 | 141 | 0.100 |
Why?
|
| Socioeconomic Factors | 2 | 2015 | 1221 | 0.100 |
Why?
|
| Cannabidiol | 1 | 2012 | 10 | 0.100 |
Why?
|
| Educational Status | 2 | 2019 | 335 | 0.090 |
Why?
|
| Linear Models | 1 | 2012 | 311 | 0.090 |
Why?
|
| Memory, Short-Term | 2 | 2013 | 56 | 0.090 |
Why?
|
| Personality Inventory | 2 | 2016 | 82 | 0.090 |
Why?
|
| Computer Simulation | 1 | 2013 | 404 | 0.090 |
Why?
|
| Unsafe Sex | 2 | 2010 | 162 | 0.090 |
Why?
|
| Predictive Value of Tests | 5 | 2012 | 438 | 0.080 |
Why?
|
| Suicide, Attempted | 1 | 2012 | 104 | 0.080 |
Why?
|
| Diffusion Magnetic Resonance Imaging | 2 | 2020 | 18 | 0.080 |
Why?
|
| Motor Skills | 1 | 2010 | 45 | 0.080 |
Why?
|
| Games, Experimental | 1 | 2009 | 4 | 0.080 |
Why?
|
| Hippocampus | 3 | 2021 | 591 | 0.080 |
Why?
|
| Affective Symptoms | 1 | 2010 | 60 | 0.080 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 2011 | 276 | 0.080 |
Why?
|
| Severity of Illness Index | 5 | 2016 | 708 | 0.070 |
Why?
|
| Age Factors | 3 | 2006 | 1139 | 0.070 |
Why?
|
| Retrospective Studies | 2 | 2012 | 2485 | 0.070 |
Why?
|
| Smoking | 1 | 2015 | 1019 | 0.070 |
Why?
|
| Homosexuality, Male | 1 | 2013 | 483 | 0.070 |
Why?
|
| Stroop Test | 2 | 2021 | 2 | 0.070 |
Why?
|
| Diagnostic Imaging | 1 | 2007 | 53 | 0.070 |
Why?
|
| Aspartic Acid | 2 | 2005 | 51 | 0.070 |
Why?
|
| Animals | 3 | 2023 | 16695 | 0.060 |
Why?
|
| Confidence Intervals | 1 | 2007 | 162 | 0.060 |
Why?
|
| Reference Standards | 1 | 2006 | 55 | 0.060 |
Why?
|
| Psychiatric Status Rating Scales | 1 | 2007 | 280 | 0.060 |
Why?
|
| Didanosine | 1 | 2005 | 3 | 0.060 |
Why?
|
| Mitochondrial Diseases | 1 | 2005 | 19 | 0.060 |
Why?
|
| Reverse Transcriptase Inhibitors | 1 | 2005 | 56 | 0.060 |
Why?
|
| Waste Disposal, Fluid | 1 | 2025 | 19 | 0.060 |
Why?
|
| Temperament | 1 | 2005 | 36 | 0.060 |
Why?
|
| Cross-Cultural Comparison | 1 | 2005 | 109 | 0.060 |
Why?
|
| Sensitivity and Specificity | 2 | 2004 | 602 | 0.060 |
Why?
|
| Neurodegenerative Diseases | 1 | 2006 | 138 | 0.050 |
Why?
|
| Verbal Behavior | 1 | 2004 | 11 | 0.050 |
Why?
|
| Central Nervous System Stimulants | 1 | 2006 | 181 | 0.050 |
Why?
|
| T-Lymphocytes | 1 | 2006 | 378 | 0.050 |
Why?
|
| Eclampsia | 1 | 2023 | 13 | 0.050 |
Why?
|
| Language | 1 | 2005 | 181 | 0.050 |
Why?
|
| Diagnosis, Dual (Psychiatry) | 2 | 2015 | 44 | 0.050 |
Why?
|
| Diagnosis, Computer-Assisted | 1 | 2003 | 21 | 0.050 |
Why?
|
| Hypertension, Pregnancy-Induced | 1 | 2023 | 26 | 0.050 |
Why?
|
| Birth Weight | 1 | 2023 | 94 | 0.050 |
Why?
|
| Pre-Eclampsia | 1 | 2023 | 68 | 0.050 |
Why?
|
| Psychopathology | 1 | 2021 | 20 | 0.050 |
Why?
|
| Personality Disorders | 1 | 2021 | 21 | 0.050 |
Why?
|
| Lymphocyte Count | 1 | 2021 | 47 | 0.050 |
Why?
|
| Incidental Findings | 1 | 2021 | 11 | 0.040 |
Why?
|
| Task Performance and Analysis | 1 | 2021 | 47 | 0.040 |
Why?
|
| Filtration | 1 | 2021 | 17 | 0.040 |
Why?
|
| Pancreas | 1 | 2021 | 45 | 0.040 |
Why?
|
| Oncogenes | 1 | 2021 | 44 | 0.040 |
Why?
|
| Awareness | 1 | 2021 | 73 | 0.040 |
Why?
|
| Kenya | 1 | 2021 | 56 | 0.040 |
Why?
|
| Organoids | 1 | 2021 | 33 | 0.040 |
Why?
|
| RNA, Viral | 1 | 2022 | 317 | 0.040 |
Why?
|
| Rural Population | 1 | 2023 | 352 | 0.040 |
Why?
|
| Genome, Viral | 1 | 2021 | 118 | 0.040 |
Why?
|
| Referral and Consultation | 1 | 2021 | 141 | 0.040 |
Why?
|
| Stem Cells | 1 | 2021 | 151 | 0.040 |
Why?
|
| Florida | 1 | 2021 | 461 | 0.040 |
Why?
|
| Prevalence | 2 | 2019 | 1597 | 0.040 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2021 | 379 | 0.040 |
Why?
|
| Signal Processing, Computer-Assisted | 1 | 2019 | 67 | 0.040 |
Why?
|
| National Institute of Mental Health (U.S.) | 1 | 2018 | 4 | 0.040 |
Why?
|
| Habits | 1 | 2018 | 8 | 0.040 |
Why?
|
| South America | 1 | 2018 | 22 | 0.040 |
Why?
|
| Delphi Technique | 1 | 2018 | 30 | 0.040 |
Why?
|
| North America | 1 | 2018 | 85 | 0.040 |
Why?
|
| Europe | 1 | 2018 | 114 | 0.040 |
Why?
|
| Asia | 1 | 2018 | 99 | 0.040 |
Why?
|
| Australia | 1 | 2018 | 95 | 0.040 |
Why?
|
| Compulsive Behavior | 1 | 2018 | 31 | 0.040 |
Why?
|
| Aged | 2 | 2012 | 7982 | 0.040 |
Why?
|
| Nutrition Surveys | 1 | 2019 | 263 | 0.040 |
Why?
|
| Infant, Newborn | 1 | 2021 | 960 | 0.030 |
Why?
|
| Pregnancy | 1 | 2023 | 1737 | 0.030 |
Why?
|
| Personality Tests | 1 | 2016 | 7 | 0.030 |
Why?
|
| Culture | 1 | 2018 | 172 | 0.030 |
Why?
|
| Child, Preschool | 1 | 2021 | 1516 | 0.030 |
Why?
|
| Analgesics, Opioid | 1 | 2019 | 245 | 0.030 |
Why?
|
| Legislation, Drug | 1 | 2016 | 6 | 0.030 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 2 | 2010 | 456 | 0.030 |
Why?
|
| Statistics, Nonparametric | 1 | 2016 | 113 | 0.030 |
Why?
|
| ROC Curve | 2 | 2004 | 157 | 0.030 |
Why?
|
| Wechsler Scales | 1 | 2013 | 7 | 0.030 |
Why?
|
| Reading | 1 | 2013 | 13 | 0.030 |
Why?
|
| Principal Component Analysis | 1 | 2013 | 87 | 0.030 |
Why?
|
| Chicago | 1 | 2013 | 30 | 0.030 |
Why?
|
| Magnetic Resonance Spectroscopy | 2 | 2005 | 300 | 0.020 |
Why?
|
| Hypertension | 1 | 2019 | 823 | 0.020 |
Why?
|
| Hospitals, Veterans | 1 | 2012 | 16 | 0.020 |
Why?
|
| Association Learning | 1 | 2012 | 34 | 0.020 |
Why?
|
| Patient Compliance | 1 | 2013 | 225 | 0.020 |
Why?
|
| Antiviral Agents | 1 | 2013 | 189 | 0.020 |
Why?
|
| Postoperative Complications | 1 | 2013 | 253 | 0.020 |
Why?
|
| Algorithms | 1 | 2013 | 508 | 0.020 |
Why?
|
| Avoidance Learning | 1 | 2010 | 68 | 0.020 |
Why?
|
| Diagnostic and Statistical Manual of Mental Disorders | 1 | 2010 | 116 | 0.020 |
Why?
|
| Data Interpretation, Statistical | 1 | 2010 | 126 | 0.020 |
Why?
|
| Psychological Tests | 1 | 2007 | 56 | 0.020 |
Why?
|
| HIV Seronegativity | 1 | 2007 | 41 | 0.020 |
Why?
|
| Chi-Square Distribution | 1 | 2007 | 236 | 0.020 |
Why?
|
| Putamen | 1 | 2006 | 16 | 0.020 |
Why?
|
| Stavudine | 1 | 2005 | 13 | 0.010 |
Why?
|
| Lamivudine | 1 | 2005 | 22 | 0.010 |
Why?
|
| Zidovudine | 1 | 2005 | 31 | 0.010 |
Why?
|
| Cell Respiration | 1 | 2005 | 35 | 0.010 |
Why?
|
| Microscopy, Confocal | 1 | 2006 | 223 | 0.010 |
Why?
|
| Matched-Pair Analysis | 1 | 2004 | 10 | 0.010 |
Why?
|
| Area Under Curve | 1 | 2004 | 95 | 0.010 |
Why?
|
| Cerebral Cortex | 1 | 2006 | 303 | 0.010 |
Why?
|
| Semantics | 1 | 2004 | 29 | 0.010 |
Why?
|
| Phosphocreatine | 1 | 2003 | 12 | 0.010 |
Why?
|
| Creatine | 1 | 2003 | 10 | 0.010 |
Why?
|
| Inositol | 1 | 2003 | 20 | 0.010 |
Why?
|
| Disease Progression | 1 | 2006 | 661 | 0.010 |
Why?
|
| Frontal Lobe | 1 | 2003 | 58 | 0.010 |
Why?
|
| Blotting, Western | 1 | 2004 | 884 | 0.010 |
Why?
|
| Mitochondria | 1 | 2005 | 516 | 0.010 |
Why?
|
| Clinical Trials as Topic | 1 | 2003 | 249 | 0.010 |
Why?
|
| Motor Activity | 1 | 2004 | 438 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2005 | 1586 | 0.010 |
Why?
|
| Aging | 1 | 2005 | 764 | 0.010 |
Why?
|
| Chronic Disease | 1 | 2003 | 541 | 0.010 |
Why?
|